SCHEMBL1586450

SCHEMBL1586450

CC(C)Cn1c(=O)c(C(=O)NCC(=O)O)c(O)c2nc3ccccc3n21

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 6/20 0.44
LMNA P02545 2/20 0.43
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HIF1A Q16665 8/20 0.41
BBOX1 O75936 1/20 0.41
ASPH Q12797 1/20 0.41
KDM8 Q8N371 1/20 0.41
EGFR P00533 1/20 0.40
SRC P12931 1/20 0.40
EGLN3 Q9H6Z9 3/20 0.40
EGLN2 Q96KS0 1/20 0.40
HSP90AA1 P07900 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1585822 0.89 EGLN1 (0.47) EGLN1LMNATSHRHTTSMN1; SMN2
SCHEMBL1586015 0.87 EGLN1 (0.45) EGLN1LMNAUSP2TSHRSMN1; SMN2
SCHEMBL1586272 0.86 EGLN1 (0.46) EGLN1ALDH1A1HTTHIF1ABBOX1
SCHEMBL1585687 0.86 EGLN1 (0.56) EGLN1EGLN3EGLN2
SCHEMBL1585620 0.84 EGLN1 (0.48) EGLN1HIF1ABBOX1ASPHKDM8
SCHEMBL1585869 0.83 EGLN1 (0.47) EGLN1LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL1586363 0.82 EGLN1 (0.50) EGLN1HIF1AEGLN3EGLN2
SCHEMBL1585836 0.82 EGLN1 (0.48) EGLN1ALDH1A1NPSR1HIF1ABBOX1
SCHEMBL1585642 0.82 EGLN1 (0.50) EGLN1EGLN3EGLN2
SCHEMBL1585697 0.82 EGLN1 (0.48) EGLN1HIF1ABBOX1ASPHKDM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048611-A1 NOVEL FUSED PYRIDAZINE DERIVATIVES TORRENT PHARMACEUTICALS LIMITED (IN) 2011-04-28 WO claimed